checkAd
    Startseite > Aktien > Aelis Farma > Nachrichten
    Aelis Farma Aktie
    12,800
     
    EUR
    0,00 %
    0,000 EUR
    Letzter Kurs 03.05.24 Frankfurt
    12,800
     
    EUR
    120 STK
    Geldkurs 03.05.24
    13,200
     
    EUR
    120 STK
    Briefkurs 03.05.24
    ISIN: FR0014007ZB4 · WKN: A3DE66 · SYM: 69O · Frankreich

    Neueste Nachrichten

    Aelis Farma: Availability of the 2023 Universal Registration Document
    25.04.24 · Business Wire (engl.) · Aelis Farma
    Aelis Farma Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder
    18.04.24 · Business Wire (engl.) · Aelis Farma
    Aelis Farma Reports Its 2023 Annual Financial Resultsand Confirms Its 2024 Outlook
    02.04.24 · Business Wire (engl.) · Aelis Farma
    Aelis Farma Announces Its 2024 Financial Calendar
    30.01.24 · Business Wire (engl.) · Aelis Farma
    Aelis Farma Strengthens its Leadership Team with the Appointment of Arsène Guekam as Chief Corporate Development Officer
    17.01.24 · Business Wire (engl.) · Aelis Farma
    Aelis Farma Announces Completion of Patient Randomization for Phase 2b Study with AEF0117 for the Treatment of Cannabis Addiction
    09.01.24 · Business Wire (engl.) · Aelis Farma
    Aelis Farma Announces Positive Results of Non-clinical Studies Required by Regulatory Agencies to Enter Its First CB1-SSi, AEF0117, in Phase 3 Clinical Trial for the Treatment of Cannabis Use Disorder
    07.11.23 · Business Wire (engl.) · Aelis Farma
    Aelis Farma: Availability of the 2023 Half-Year Financial Report
    26.09.23 · Business Wire (engl.) · Aelis Farma
    Aelis Farma Publishes Half-Year Financial Results for 2023 and Confirms Its Development Objectives
    25.09.23 · Business Wire (engl.) · Aelis Farma
    Pier Vincenzo Piazza, CEO of Aelis Farma, Receives the Distinguished Achievement Award from the European Behavioural Pharmacology Society (EBPS)
    28.08.23 · Business Wire (engl.) · Aelis Farma
    Aelis Farma Takes Part in the 10th Edition of the Gordon Research Conference on the Role of Cannabinoid Receptors in Central Nervous System Disorders
    20.07.23 · Business Wire (engl.) · Aelis Farma
    Aelis Farma: Availability of the Description of the Share Buyback Program
    21.06.23 · Business Wire (engl.) · Aelis Farma